GSK grabs 150K square feet of prime Boston lab space as part of RNA, viral focus

GSK is continuing to grow its footprint in the biotech hub of Boston, adding 155,000 square feet of additional lab space to its site on Cambridge Park Drive as part of a focus on RNA and viral therapies.